Twin Tree Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-4,700
Closed -$735K – 1463
2025
Q3
$735K Sell
4,700
-32,700
-87% -$5.19M ﹤0.01% 1229
2025
Q2
$5.67M Buy
+37,400
New +$4.99M 0.01% 957
2023
Q3
– Sell
-3,200
Closed -$673K – 1280
2023
Q2
$673K Sell
3,200
-2,700
-46% -$537K ﹤0.01% 1052
2023
Q1
$1.19M Buy
+5,900
New +$1.34M ﹤0.01% 997
2022
Q3
– Sell
-14,500
Closed -$3.1M – 1402
2022
Q2
$3.1M Sell
14,500
-39,100
-73% -$9.6M ﹤0.01% 1010
2022
Q1
$15.2M Buy
53,600
+53,200
+13,300% +$16.4M 0.02% 570
2021
Q4
$151K Buy
+400
New +$155K ﹤0.01% 1444
2021
Q2
– Sell
-11,700
Closed -$3.39M – 1385
2021
Q1
$3.39M Buy
11,700
+11,600
+11,600% +$3.22M 0.01% 733
2020
Q4
$25K Sell
100
-56,400
-100% -$13.4M ﹤0.01% 1199
2020
Q3
$12.8M Sell
56,500
-32,000
-36% -$6.64M 0.05% 378
2020
Q2
$15.4M Buy
88,500
+61,700
+230% +$9.8M 0.06% 349
2020
Q1
$3.38M Buy
26,800
+5,700
+27% +$855K 0.02% 585
2019
Q4
$3.22M Sell
21,100
-6,700
-24% -$928K 0.01% 606
2019
Q3
$3.68M Sell
27,800
-47,200
-63% -$6.33M 0.01% 555
2019
Q2
$10.6M Sell
75,000
-20,500
-21% -$2.78M 0.05% 287
2019
Q1
$13.9M Buy
95,500
+75,000
+366% +$9.9M 0.07% 231
2018
Q4
$2.32M Buy
+20,500
New +$2.57M 0.01% 684

Other funds holding CRL

Twin Tree Management's CRL Position: Q3 2026 in Review

Twin Tree Management opened a new position in Charles River Laboratories (CRL) in Q3 2026: 5,911 shares worth $1.74M. The stake represents 0.04% of the portfolio and ranks #560 among its holdings. This is a return to the name: Twin Tree Management previously reported a position in CRL as recently as Q3 2025.

Twin Tree Management first reported a position in CRL in Q2 2018 and has held it in 17 quarters since. The position peaked at $7.44M in Q1 2022. 646 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • Twin Tree Management held 5,911 shares of Charles River Laboratories worth $1.74M as of Q3 2026.
  • Charles River Laboratories was a new Twin Tree Management position in Q3 2026.
  • Charles River Laboratories made up 0.04% of Twin Tree Management's portfolio in Q3 2026, its #560 holding.
  • Twin Tree Management first reported a position in Charles River Laboratories in Q2 2018 and has held it in 17 quarters since.
  • Twin Tree Management's Charles River Laboratories position peaked at $7.44M in Q1 2022.
  • 646 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on Twin Tree Management's 13F filing for Q3 2026, filed 10 Nov 2026.